Cytokines involved in the severe manifestations of pulmonary diseases caused by Mycoplasma pneumoniae [1]

Pediatric Pulmonology

Volumn 42, Issue 4, 2007, Pages 397-

  Narita, Mitsuo ^a   Tanaka, Hiroshi ^b  

^a Sapporo Tetsudo JR Hospital   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 18 BINDING PROTEIN;

CYTOKINE RELEASE; DISEASE SEVERITY; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOPATHOGENESIS; LETTER; LUNG INFECTION; MYCOPLASMA PNEUMONIAE; PRIORITY JOURNAL;

GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-18; LUNG; PNEUMONIA, MYCOPLASMA; SEVERITY OF ILLNESS INDEX;

EID: 34247215152     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20445     Document Type: Letter

References (4)

1. Lee KY, Lee HS, Hong JH, Lee MH, Lee JS, Burgner D, Lee BC. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol 2006;41:263-268.
2. Narita M, Tanaka H, Abe S, Yamada S, Kubota M, Togashi T. Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon. Clin Diagn Lab Immunol 2000;7:909-914.
3. Narita M, Tanaka H, Yamada S, Abe S, Ariga T, Sakiyama Y. Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection. Clin Diagn Lab Immunol 2001;8:1028-1030.
4. Tanaka H, Narita M, Teramoto S, Saikai T, Oashi K, Igarashi T, Abe S. Role of interleukin-18 and T helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults. Chest 2002;121:1493-1497.